Latest filing published 20 Mar 2009 for Lev Pharmaceuticals Inc, €1.2M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Mast Credit Opportunities I Master Fund Ltd span 2 companies, the busiest being Lev Pharmaceuticals Inc and First Albany Companies Inc. The record holds 21 filings, for trades running from 4 March 2008 to 21 October 2008.
The open-market record is one-sided, with 19 purchases worth €8.9M and not one sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.
In size, the median ticket on the buying side is €3,850.
Most recently, on 20 March 2009, the filings show a transaction worth €37.6M in Lev Pharmaceuticals Inc. The clock since the last published purchase (2 October 2008) now reads 6,596 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations